Medical Devices; Immunology and Microbiology Devices;   Classification of Autosomal Recessive Carrier Screening Gene Mutation Detection System. Final order.
The Food and Drug Administration (FDA) has classified an autosomal recessive carrier screening gene mutation detection system into class II (special controls). The special controls that apply to this device are identified in this order and will be part of the codified language for the autosomal recessive carrier screening gene mutation detection system classification. The Agency has classified the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
D018795:Device Approval / Q000331:legislation & jurisprudence*; D004869:Equipment Safety / Q000145:classification*; D005808:Genes, Recessive / Q000235:genetics*; D005820:Genetic Testing / Q000145:classification* / Q000295:instrumentation*; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D066298:In Vitro Techniques / Q000145:classification* / Q000295:instrumentation*; D009154:Mutation / Q000235:genetics*; D014481:United States